Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,940 | -32,239 | -17,137 | -97,744 | -73,371 |
| Depreciation Amortization | 6,146 | 4,054 | 537 | 18,149 | 6,956 |
| Accounts receivable | -4,330 | -2,078 | 5,743 | -3,021 | -1,381 |
| Accounts payable and accrued liabilities | -6,880 | -7,975 | -5,958 | 111 | 3,692 |
| Other Working Capital | 3,764 | 3,422 | 5,411 | -1,153 | 3,079 |
| Other Operating Activity | 42,476 | 14,080 | 7,249 | 18,611 | 10,837 |
| Operating Cash Flow | $-26,764 | $-20,736 | $-4,155 | $-65,047 | $-50,188 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,500 | 8,500 | 8,500 | -8,500 | -12,000 |
| PPE Investments | -198 | -176 | -13 | -115 | -112 |
| Sale Of Investment | N/A | N/A | N/A | 475 | 475 |
| Investing Cash Flow | $8,302 | $8,324 | $8,487 | $-8,140 | $-11,637 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16,221 | 16,221 | 713 | 82,542 | 62,719 |
| Other Financing Activity | -11,969 | -6,248 | -5,657 | -9,080 | -6,829 |
| Financing Cash Flow | $4,252 | $9,973 | $-4,944 | $73,462 | $55,890 |
| Exchange Rate Effect | -60 | -47 | -15 | -96 | -105 |
| Beginning Cash Position | 29,474 | 29,474 | 29,474 | 29,295 | 29,295 |
| End Cash Position | 15,204 | 26,988 | 28,847 | 29,474 | 23,254 |
| Net Cash Flow | $-14,270 | $-2,486 | $-627 | $179 | $-6,041 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,764 | -20,736 | -4,155 | -65,047 | -50,188 |
| Capital Expenditure | -198 | -176 | -13 | -115 | -112 |
| Free Cash Flow | -26,962 | -20,912 | -4,168 | -65,162 | -50,300 |